Big Pharma Steps Onto the Psychedelics Wagon

Big Pharma Steps Onto the Psychedelics Wagon

The world of medicine is constantly evolving as more and more research is conducted and breakthroughs are made. One area that has been garnering a lot of attention lately is the use of psychedelics in mental health treatment. And it seems that Big Pharma is taking notice.
'Psilocybin Has Been Extremely Effective': Firefighter Advocates for Decriminalization

‘Psilocybin Has Been Extremely Effective’: Firefighter Advocates for Decriminalization

"There are countless first responders, veterans and people across California who could benefit," says a retired New York City fireman.
Psilocybin v. Escitalopram: Study Compares Effects on Depression

Psilocybin v. Escitalopram: Study Compares Effects on Depression

Researchers probe treating one of the greatest psychological issues of our time with two different drugs.
Over One-Third of Under 50s Open to Psychedelic Trials for Mental Health Treatment

Over One-Third of Under 50s Are Open to Psychedelic Trials for Mental Health Treatment

Aside from psilocybin, those aged between 18-24 were most interested psychedelic trials with ketamine (27%) and MDMA (26%).
Artechouse's 'Beyond The Light Exhibition is NASA and AI inspired Psychedelic OdysseyArtechouse

NASA-Inspired Psychedelic Odyssey: Artechouse’s ‘Beyond the Light’ Exhibit Is a Spacetime Trip

,
Artechouse’s 25-minute cosmic exhibit merges stunning psychedelic imagery, immortalized by NASA's James Webb Space Telescope, with AI-aided visual production, pushing the boundaries of our imagination and "celebrating the spirit of exploration, discovery, and creation in our universe."

The Biggest Psychedelic News Stories of the Week – August 21st

,
Red Light Holland's psilocybin capsules clear stability tests for Australian distribution, as new research explores psychedelics' impact on neural synchronization and consciousness, while Oregon's psilocybin therapy shows promising mental health benefits-but don't expect insurance coverage just yet.
Removing Barriers of Accessibility to Psychedelics with Brett Waters

Removing Barriers of Accessibility to Psychedelics with Brett Waters

Brett also introduces the collaborative efforts of Reason for Hope's team, which includes strategic minds from various fields, working together in drafting legislation, preparing legal briefings, educating legislators, and building advocacy coalitions. Currently, Reason for Hope focuses on establishing MDMA- and psilocybin-assisted therapy expanded access pilot programs for those unable to wait for FDA approval.
New Study Will Investigate Psilocybin Therapy for Gambling Addiction

New Study Will Investigate Psilocybin Therapy for Gambling Addiction

Researchers at Imperial’s Centre for Psychedelic Research will investigate psilocybin-assisted therapy for gambling addiction, aiming to improve their understanding of brain function in gambling disorder.
30 Days, 30 Psychedelic Retreats - Lessons Learned From Our Quest to Study Central American Retreats and Their Potential to Heal Minds

30 Days, 30 Psychedelic Retreats – Lessons Learned From Our Quest to Study Central American Retreats and Their Potential to Heal Minds

,
My journey through 30 retreats made it quite clear that every center has a somewhat unique philosophy of care. With much of the science still early and murky, it’s difficult to say that one approach is better or worse than any others.
Canadian Psychedelic Users Self-Medicating, But Few Discuss with Healthcare Providers, Says Recent Survey

Canadian Psychedelic Users Self-Medicating, But Few Discuss with Healthcare Providers, Says Recent Survey

,
Insights from a Canadian survey reveal that while more than a third use natural psychedelics to self-medicate a health condition, few discuss their use with health care providers or test their substances.